← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2009Last known activity
Mar 31, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 7 trials)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (7)
- NCT06867198CollaboratorN/AMar 31, 2025
- NCT06916936CollaboratorN/AFeb 9, 2025
- NCT05532007CollaboratorN/AMar 29, 2022
- NCT04707963CollaboratorN/AFeb 6, 2021
- NCT04015479CollaboratorN/ASep 1, 2019
- NCT03654651CollaboratorPhase 2Oct 1, 2018
- NCT01173042CollaboratorPhase 1Aug 1, 2009
Details
- Last known activity
- Mar 31, 2025